These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9456659)

  • 1. Inhibition of HIV infectivity by human saliva.
    Malamud D; Nagashunmugam T; Davis C; Kennedy S; Abrams WR; Kream R; Friedman HM
    Oral Dis; 1997 May; 3 Suppl 1():S58-63. PubMed ID: 9456659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus.
    Nagashunmugam T; Malamud D; Davis C; Abrams WR; Friedman HM
    J Infect Dis; 1998 Dec; 178(6):1635-41. PubMed ID: 9815215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro inhibition of HIV-1 infectivity by human salivas.
    Archibald DW; Cole GA
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1425-32. PubMed ID: 2078420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 IIIB and clinical isolates by human parotid, submandibular, sublingual and palatine saliva.
    Bolscher JG; Nazmi K; Ran LJ; van Engelenburg FA; Schuitemaker H; Veerman EC; Nieuw Amerongen AV
    Eur J Oral Sci; 2002 Apr; 110(2):149-56. PubMed ID: 12013559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human submandibular saliva specifically inhibits HIV type 1.
    Nagashunmugam T; Friedman HM; Davis C; Kennedy S; Goldstein LT; Malamud D
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):371-6. PubMed ID: 9075477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of human saliva on HIV-1 infectivity].
    Etsuko K; Wei S
    Nihon Rinsho Meneki Gakkai Kaishi; 2001 Aug; 24(4):152-9. PubMed ID: 16578966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human submandibular saliva aggregates HIV.
    Malamud D; Davis C; Berthold P; Roth E; Friedman H
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):633-7. PubMed ID: 8396401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory function of secretory leukocyte proteinase inhibitor (SLPI) in human saliva is HIV-1 specific and varies with virus tropism.
    Skott P; Lucht E; Ehnlund M; Björling E
    Oral Dis; 2002 May; 8(3):160-7. PubMed ID: 12108760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggregation of human immunodeficiency virus type 1 by human salivary secretions.
    Bergey EJ; Cho MI; Hammarskjöld ML; Rekosh D; Levine MJ; Blumberg BM; Epstein LG
    Crit Rev Oral Biol Med; 1993; 4(3-4):467-74. PubMed ID: 8373999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parotid salivary basic proline-rich proteins inhibit HIV-I infectivity.
    Robinovitch MR; Ashley RL; Iversen JM; Vigoren EM; Oppenheim FG; Lamkin M
    Oral Dis; 2001 Mar; 7(2):86-93. PubMed ID: 11355444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Submandibular salivary proteases: lack of a role in anti-HIV activity.
    Kennedy S; Davis C; Abrams WR; Billings PC; Nagashunmugam T; Friedman H; Malamud D
    J Dent Res; 1998 Jul; 77(7):1515-9. PubMed ID: 9663436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secretory leukocyte protease inhibitor blocks infectivity of primary monocytes and mononuclear cells with both monocytotropic and lymphocytotropic strains of human immunodeficiency virus type I.
    Shugars DC; Sauls DL; Weinberg JB
    Oral Dis; 1997 May; 3 Suppl 1():S70-2. PubMed ID: 9456661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anatomic dissociation between HIV-1 and its endogenous inhibitor in mucosal tissues.
    Wahl SM; Worley P; Jin W; McNeely TB; Eisenberg S; Fasching C; Orenstein JM; Janoff EN
    Am J Pathol; 1997 Apr; 150(4):1275-84. PubMed ID: 9094984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.
    McNeely TB; Dealy M; Dripps DJ; Orenstein JM; Eisenberg SP; Wahl SM
    J Clin Invest; 1995 Jul; 96(1):456-64. PubMed ID: 7615818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-infectivity activity of human salivary secretions toward human immunodeficiency virus.
    Robinovitch MR; Iversen JM; Resnick L
    Crit Rev Oral Biol Med; 1993; 4(3-4):455-9. PubMed ID: 8397002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies of salivary inhibition of HIV-1 infectivity.
    Yeh CK; Handelman B; Fox PC; Baum BJ
    J Acquir Immune Defic Syndr (1988); 1992; 5(9):898-903. PubMed ID: 1512690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes.
    Baron S; Poast J; Cloyd MW
    Arch Intern Med; 1999 Feb; 159(3):303-10. PubMed ID: 9989543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous salivary inhibitors of human immunodeficiency virus.
    Shugars DC; Alexander AL; Fu K; Freel SA
    Arch Oral Biol; 1999 Jun; 44(6):445-53. PubMed ID: 10401522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of human salivas on recombinant HIV-1 proteins.
    Archibald DW; Hebert CA; Gregory KL; Lewis GK
    Crit Rev Oral Biol Med; 1993; 4(3-4):475-8. PubMed ID: 8374000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A microassay for determination of the cytopathogenicity of human immunodeficiency virus type-1 isolates.
    Benyoucef S; Hober D; Shen L; Ajana F; Gérard Y; Bocket-Mouton L; Mouton Y; Wattré P
    Microbiol Immunol; 1996; 40(5):381-8. PubMed ID: 8805103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.